Skip to main content
Rebecca Wallace

Miss Rebecca Wallace

Research student


I'm a third year PhD student working on developing new caner virotherapy platforms. 

In my lab, supervised by Professor Alan Parker, we develop new adenovirus-based vectors, which can be used as cancer therapies, gene-therapy- or vaccine vectors. I am funded by CRUK and co-supervised by Dr Carly Bliss and Professor Awen Gallimore

In my thesis, titled "Development of Precision Virotherapies Capapble of Evading Host Anti-Vector Immunity" I will be exploring how population immunity to Ad5, the most commonly used Adenovirus vector, can be circumvented to better deliver therapies to patients.






Alan Parker

Alan Parker

Professor of Translational Virotherapies. Head of Section of Solid Cancers, Division of Cancer and Genetics